These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6239)

  • 1. [Comparative studies on the characterization of the beta-receptor stimulating properties of tetrahydropapaverolin].
    Rohte O; Ochlich P
    Dtsch Tierarztl Wochenschr; 1976 May; 83(5):178-88. PubMed ID: 6239
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ethaverin, a coronary dilator with beta-receptor depressing and antiarrhythmia myocardial effects].
    Fleckenstein A; Grün G; Döring HJ; Haastert HP; Tritthart H
    Med Welt; 1973 Mar; 24(12):441-9. PubMed ID: 4144783
    [No Abstract]   [Full Text] [Related]  

  • 3. Beta-adrenoceptor blocking agents and their effects on heart and blood vessels.
    Clark BJ
    Arq Bras Cardiol; 1984 Apr; 42(4):237-42. PubMed ID: 6150700
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of 4-(2-hydroxy-3-isopropylaminopropoxy) acetanilide (AY 21,011) on the myocardial and coronary vascular responses to adrenergic stimulation.
    Lucchesi BR; Hodgeman RJ
    J Pharmacol Exp Ther; 1971 Jan; 176(1):200-11. PubMed ID: 4398216
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E; Murai T; Ishizaka Y; Sanai K
    Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent beta-adrenoreceptor stimulants.
    Brittain RT; Jack D; Ritchie AC
    Adv Drug Res; 1970; 5():197-253. PubMed ID: 4395724
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro studies on the cardiac activity of prenalterol with reference to use in congestive heart failure.
    Kenakin TP; Beek D
    J Pharmacol Exp Ther; 1982 Jan; 220(1):77-85. PubMed ID: 6118432
    [No Abstract]   [Full Text] [Related]  

  • 8. Bamethan A competitive betamimetic drug.
    Marmo E; Saini RK; Caputi AP
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):247-72. PubMed ID: 4152789
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of alkyl substitution in drugs. XX. Some pharmacological investigations into a series of 1-(o-alkylphenyl)-2-methyl and 1-(o-alkylphenyl)-2-ethylcyclohexanols.
    Timmerman H; Mulder D; Nauta WT
    Arzneimittelforschung; 1969 Aug; 19(8):1254-7. PubMed ID: 4390181
    [No Abstract]   [Full Text] [Related]  

  • 10. Puerarin beta-adrenergic receptor blocking effect.
    Lu XR; Gao E; Xu LZ; Li HZ; Kang B; Chen WN; Chen SM; Chai XS
    Chin Med J (Engl); 1987 Jan; 100(1):25-8. PubMed ID: 2885157
    [No Abstract]   [Full Text] [Related]  

  • 11. The pharmacological characterization of beta-sympathicolytic substances.
    Saameli K
    Indian Heart J; 1972 Jun; 24():Suppl 1:146-56. PubMed ID: 4147272
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent].
    Brunner H; Hedwall PR; Meier M
    Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373
    [No Abstract]   [Full Text] [Related]  

  • 13. Does myocardial adenyl cyclase represent the cardiac beta-receptor?
    Strosberg AM; Waterbury LD
    Proc West Pharmacol Soc; 1976; 19():466-9. PubMed ID: 11505
    [No Abstract]   [Full Text] [Related]  

  • 14. [Leukotrienes and the cardiovascular system].
    Sagach VF
    Patol Fiziol Eksp Ter; 1986; (1):84-9. PubMed ID: 3010220
    [No Abstract]   [Full Text] [Related]  

  • 15. Distinct cardioselectivity of TR2732, a new beta adrenergic blocking agent.
    Reyes G; Ramírez T; Hong E
    Proc West Pharmacol Soc; 1991; 34():141-4. PubMed ID: 1686323
    [No Abstract]   [Full Text] [Related]  

  • 16. [Optical antipodes of adrenergic beta receptor blocking agent 1-(o-allyloxyphenoxy)-3-isopropylamino-2-propanol].
    Meier M; Hedwall PR; Imhof P; Wilhelm M; Brunner H
    Arzneimittelforschung; 1970 Dec; 20(12):1890-6. PubMed ID: 4395650
    [No Abstract]   [Full Text] [Related]  

  • 17. Myocardial effects of phentolamine.
    Das PK; Parratt JR
    Br J Pharmacol; 1970 Sep; 40(1):150P-151P. PubMed ID: 4395081
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacology of recent beta-adrenoceptor stimulants.
    Brittain RT
    Proc R Soc Med; 1972 Sep; 65(9):759-61. PubMed ID: 4404401
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacology of 1-phenylaminoethylamino-3-(phenoxy)propanol derivatives with beta-adrenergic action].
    Femmer K; Heer S; Poppe H
    Pharmazie; 1983 Jun; 38(6):409-14. PubMed ID: 6136994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenergic blocking properties of Citanest.
    Sharaf EM; Abdel-Wahed SA; Youakim S; Saad Y; el-Khateeb MS; Taha A
    J Egypt Med Assoc; 1977; 60(1-2):61-70. PubMed ID: 606734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.